SANE/SART Services for Sexual Assault Victims: Policy Implications
Wolbert Burgess, Ann, Lewis-O'Connor, Annie, Elaine Nugent-Borakove, M., Fanflik, Patricia
Published in Victims & offenders (01.09.2006)
Published in Victims & offenders (01.09.2006)
Get full text
Journal Article
Abstract P4-07-07: Triple targeted combination therapy with tucatinib, palbociclib and fulvestrant is active in hormone receptor and HER2-positive human breast tumor cell lines
Shagisultanova, E, Borakove, M, Kabos, P, Borges, V
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract OT1-03-06: Phase IB/II clinical trial to evaluate safety and efficacy of tucatinib in combination with palbociclib and letrozole in patients with hormone receptor positive and HER2-positive metastatic breast cancer
Shagisultanova, E, Diamond, J, Stopeck, A, Pusztai, L, O'Regan, R, Gradishar, W, Brown-Glaberman, U, Chalasani, P, McSpadden, T, Borakove, M, Shedin, T, Kabos, P, Borges, V
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P4-04-06: Young women's breast cancer is characterized by increased immune suppression through circulating myeloid derived supressor cells
Borges, VF, Ramirez, O, Borakove, M, Manthey, E, Diamond, JR, Elias, AD, Finlayson, C, Kounalakis, N, Jordan, K
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article